المؤلفون: Iida, S, Ishikawa, T, Min, CK, Kim, K, Yeh, SP, Usmani, SZ, Mateos, MV, Nahi, H, Heuck, C, Qin, X, Parasrampuria, DA, Gries, KS, Qi, M, Bahlis, N, Ito, S

المصدر: Annals of hematology. 101(100):1065-1077

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:145935548

المؤلفون: Perrot, A, Facon, T, Plesner, T, Usmani, SZ, Kumar, S, Bahlis, NJ, Hulin, C, Orlowski, RZ, Nahi, H, Mollee, P, Ramasamy, K, Roussel, M, Jaccard, A, Delforge, M, Karlin, L, Arnulf, B, Chari, A, He, JM, Ho, KF, Van Rampelbergh, R, Uhlar, CM, Wang, JP, Kobos, R, Gries, KS, Fastenau, J, Weisel, K

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(3):227

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:146196339

المؤلفون: Usmani, SZ, Mateos, MV, Hungria, V, Iida, S, Bahlis, NJ, Nahi, H, Magen, H, Cavo, M, Hulin, C, White, D, De Stefano, V, Fastenau, J, Slavcev, M, Heuck, C, Qin, X, Pei, HL, Masterson, T, Lantz, K, Gries, KS

المصدر: Journal of cancer research and clinical oncology. 147(3):619-631

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:144584482

المؤلفون: Silbermann R; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Laubach J; Department of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts, USA., Kaufman JL; Department of Mematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Sborov DW; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA., Reeves B; Division of Hematology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA., Rodriguez C; Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA., Chari A; Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA., Costa LJ; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Anderson LD Jr; Division of Hematology/Oncology, Simmons Comprehensive Cancer Center, UT Texas Southwestern Medical Center, Dallas, Texas, USA., Nathwani N; Division of Myeloma, Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA., Shah N; Department of Medicine, University of California San Francisco, San Francisco, California, USA., Bumma N; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Holstein SA; Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Costello C; Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego, La Jolla, California, USA., Jakubowiak A; Medicine- Hematology and Oncology, University of Chicago, Chicago, Illinois, USA., Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shain KH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Cowan AJ; Department of Medicine, University of Washington, Seattle, Washington, USA., Gries KS; Janssen Research & Development, Raritan, New Jersey, USA., Pei H; Janssen Research & Development, LLC, Titusville, New Jersey, USA., Cortoos A; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA., Patel S; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA., Lin TS; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA., Voorhees PM; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health/Wake Forest University School of Medicine, Charlotte, North Carolina, USA., Usmani SZ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Richardson PG; Department of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts, USA.

المصدر: American journal of hematology [Am J Hematol] 2024 Jul; Vol. 99 (7), pp. 1257-1268. Date of Electronic Publication: 2024 Apr 15.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Quality of Life* , Bortezomib*/administration & dosage , Bortezomib*/therapeutic use , Dexamethasone*/administration & dosage , Dexamethasone*/therapeutic use , Lenalidomide*/administration & dosage , Lenalidomide*/therapeutic use , Patient Reported Outcome Measures* , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antibodies, Monoclonal*/therapeutic use , Antibodies, Monoclonal*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult

المؤلفون: Martin TG; University of California San Francisco, San Francisco, CA. Electronic address: Tom.Martin@ucsf.edu., Moreau P; Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France., Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC., Garfall A; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Mateos MV; University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain., San-Miguel JF; Clínica Universidad de Navarra (CCUN), CIMA, CIBERONC, IDISNA, Pamplona, Spain., Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain., Nooka AK; Winship Cancer Institute, Emory University, Atlanta, GA., Rosinol L; Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain., Chari A; Mount Sinai School of Medicine, New York, NY., Karlin L; Service d'Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Krishnan A; City of Hope Comprehensive Cancer Center, Duarte, CA., Bahlis N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Popat R; University College London Hospitals, NHS Foundation Trust, London, UK., Besemer B; University of Tuebingen, Tuebingen, Germany., Martínez-López J; Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC, Madrid, Spain., Delforge M; Universitaire Ziekenhuizen Leuven, Leuven, Belgium., Trancucci D; Janssen Research & Development, Raritan, NJ., Pei L; Janssen Research & Development, Raritan, NJ., Kobos R; Janssen Research & Development, Raritan, NJ., Fastenau J; Janssen Research & Development, Raritan, NJ., Gries KS; Janssen Research & Development, Raritan, NJ., van de Donk NWCJ; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Mar; Vol. 24 (3), pp. 194-202. Date of Electronic Publication: 2023 Nov 14.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Antineoplastic Agents*/therapeutic use, Humans ; Quality of Life ; Neoplasm Recurrence, Local/drug therapy ; Pain/drug therapy ; Patient Reported Outcome Measures

المؤلفون: Perrot, A, Facon, T, Plesner, T, Usmani, S, Kumar, SK, Bahlis, NJ, Hulin, C, Orlowski, RZ, Nahi, H, Mollee, P, Ramasamy, K, Roussel, M, Jaccard, A, Delforge, M, Karlin, L, Arnulf, B, Chari, A, Pei, H, Gupta, N, Kaila, S, Matt, K, Gries, KS, Carson, R, Borgsten, F, Weisel, K

المصدر: BLOOD. 140:1142-1145

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:151826347

المؤلفون: Mateos, MV, Cohen, AD, Cohen, YC, Agha, M, San-Miguel, J., Richard, S, van de Donk, NWCJ, Champlain A, De, Katz, EG, Iaconangelo, C, Braganca KC, De, Schecter, JM, Varsos, H, Corsale, C, Deraedt, W, Koneru, M, Filho O, Costa, Akram, M, Gries, KS

المصدر: In Value in Health June 2024 27(6) Supplement:S320-S320

المؤلفون: Mateos MV; University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain., Rigaudeau S; Hôpital Andre Mignot, Service d'Hematologie et d'Oncologie, Le Chesnay, France., Basu S; Royal Wolverhampton Hospitals NHS Trust and University, Wolverhampton, UK., Spicka I; Clinical Department of Haematology, 1st Medical Department, Charles University in Prague, Prague, Czech Republic., Schots R; UZ Brussel-VUB, Brussels, Belgium., Wrobel T; Uniwersytet Medyczny we Wrocławiu, Wroclaw, Poland., Cook G; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust and University of Leeds, Leeds, UK., Beksac M; Department of Hematology, Ankara University, Ankara, Turkey., Gries KS; Janssen Global Services, Raritan, NJ, USA., Kudva A; Janssen Research & Development, LLC, Raritan, NJ, USA., Tromp B; Janssen Research & Development, Leiden, The Netherlands., Van Rampelbergh R; Janssen Research & Development, Beerse, Belgium., Pei H; Janssen Research & Development, LLC, Titusville, NJ, USA., Wroblewski S; Janssen Research & Development, LLC, Spring House, PA, USA., Carson R; Janssen Research & Development, LLC, Spring House, PA, USA., Delioukina M; Janssen Research & Development, LLC, Spring House, PA, USA., White D; Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2023 Jul; Vol. 29 (5), pp. 1172-1177. Date of Electronic Publication: 2022 Sep 06.

نوع المنشور: Clinical Trial, Phase III; Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Multiple Myeloma*/drug therapy, Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bortezomib/therapeutic use ; Pandemics

المؤلفون: Tervonen T; Kielo Research, Zug, Switzerland., Duenas A; Evidera, London, England, UK., Collacott H; Evidera, London, England, UK., Lam A; Janssen Global Services LLC, Raritan, NJ, USA., Gries KS; Janssen Global Services LLC, Raritan, NJ, USA., Carson R; Janssen Research & Development LLC, Spring House, PA, USA., Trevor N; Janssen-Cilag Ltd, High Wycombe, England, UK., Krucien N; Evidera, London, England, UK., He J; Janssen Global Services LLC, Raritan, NJ, USA. Electronic address: jhe2@its.jnj.com.

المصدر: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2023 Jun; Vol. 26 (6), pp. 909-917. Date of Electronic Publication: 2023 Feb 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE

مواضيع طبية MeSH: Patient Preference* , Multiple Myeloma*/therapy, Humans ; Neoplasm Recurrence, Local ; Decision Making ; Life Expectancy ; Surveys and Questionnaires ; Choice Behavior ; Quality of Life

المؤلفون: Plesner, T, Dimopoulos, MA, Oriol, A, San-Miguel, J, Bahlis, NJ, Rabin, N, Suzuki, K, Yoon, SS, Ben-Yehuda, D, Cook, G, Goldschmidt, H, Grosicki, S, Qin, X, Fastenau, J, Garvin, W, Carson, R, Renaud, T, Gries, KS

المصدر: British Journal of Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

مصطلحات موضوعية: relapsed, refractory multiple myeloma, reported outcomes, POLLUX, daratumumab, health‐, related quality of life, patient‐

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::51f455bd5b64eeb914ae3c98d8160121
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2256